Inhibitory Effect of Benzofuran Compound on Cyclooxygenase

  • Min, Kyung-Rak (College of Pharmacy & Research Center for Bioresource and Health, Chungbuk National University) ;
  • Ahn, Ki-Young (College of Pharmacy & Research Center for Bioresource and Health, Chungbuk National University) ;
  • Chung, Eun-Yong (College of Pharmacy & Research Center for Bioresource and Health, Chungbuk National University) ;
  • Lee, Yong-Rok (School of Chemical Engineering and Technology, Yeungnam University) ;
  • Kim, Yeong-Shik (Natural Products Research Institute, Seoul National University) ;
  • Kim, Young-Soo (College of Pharmacy & Research Center for Bioresource and Health, Chungbuk National University)
  • Published : 2004.12.30

Abstract

Alpha-viniferin was previously isolated as a cyclooxygenase (COX)-2 inhibitor from Carex humilis (Cyperaceae) and is an oligomeric stilbene compound with benzofuran (BF) moieties in its chemical structure. In the present study, a chemically synthetic BF compound, named as 3,3-dimethyl-2,3,4,6,7,8,9,10,11,12,13,14,15,16,17,18-hexadecahydro-1H-benzo[b] cyclopentadeca[d]furan-1-one, was discovered to inhibit bacterial lipo polysaccharide (LPS)-induced prostaglandin $E_2$ $(PGE_2)$ production in macrophages RAW 264.7. The BF compound exhibited a selectively preferred inhibitory effect on COX-2 activity over COX-1 activity. Furthermore, BF compound inhibited LPS-induced COX-2 expression at transcription level. As a down-regulatory mechanism of COX-2 expression shown by BF compound, suppression of nuclear factor $(NF)-{\kappa}B$ activation has been demonstrated. BF compound inhibited LPS-induced $NF-{\kappa}B$ transcriptional activity and nuclear translocation of $NF-{\kappa}B$ p65, in parallel, but did not affect LPS-induced degradation of inhibitory ${\kappa}B{\alpha}$ protein $(I{\kappa}B{\alpha})$. Taken together, anti-inflammatory effect of BF compound on $PGE_2$ production was ascribed by its down-regulatory action on LPS-induced COX-2 synthesis in addition to inhibitory action on enzyme activity of COX-2.

Keywords

References

  1. Chung, E.Y., Kim, B.H., Lee, M.K, Yun, Y.-P., Lee, S.H., Min, K.R, and Kim, Y., Anti-inflammatory effect of the oligomeric stilbene alpha-viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase. Planta Med. 69, 710-714 (2003) https://doi.org/10.1055/s-2003-42787
  2. Iniguez, M.A., Martinez-Martinez, S., Punzon, C., Redondo, J.M., and Fresno, M., An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J. Biol. Chem. 275, 23627-23635 (2000) https://doi.org/10.1074/jbc.M001381200
  3. Inoue, H., Nanayama, T., Hara, S., Yokoyama, c., and Tanabe, T., The cyclic AMP response element plays an essential role in the expression of the human prostaglandin-endoperoxide synthase 2 gene in differentiated U937 monocytic cells. FEBS Lett. 350, 51-54 (1994) https://doi.org/10.1016/0014-5793(94)00731-4
  4. Kolenko, V, Bloom, T., Rayman, P., Bukowski, R, His, E., and Finke, J., Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. J. ImmunoZ. 163, 590-598 (1999)
  5. Lee, S.-H., Shin, N.-H., Kang, S.-H., Park, J.S., Chung, S.R., Min, K.R.., and Kim, Y., Alpha-viniferin: a prostaglandin H2 synthase inhibitor from root of Carex humilis. Planta Med. 64, 204-207 (1998) https://doi.org/10.1055/s-2006-957409
  6. Lee, Y.R., Kweon, H.I., Koh, W.S., Min, K.R., Kim, Y., and Lee, S.H., One-pot preparation of pyranoquinolinones by ytterbium(III) trifluoromethanesulfonate-catalyzed reactions : efficient synthesis of flindersine. Synthesis 12, 1851-1855 (2001)
  7. Marret, E, Flahault, A., Samama, C.-M., and Bonnet, F., Effects of postoperative, nonsteroidal, anti-inflammatory drugs on bleeding risk after tonsillectomy. Anesthesiology 98, 14971502 (2003) https://doi.org/10.1097/00000542-200306000-00030
  8. Moon, K.Y., Hahn, B.S.. Lee, J., and Kim, Y.S., A cell-based assay system for monitoring NF-kappaB activity in human HaCat transfectant cells. Anal. Biochem. 292, 17-21 (2001) https://doi.org/10.1006/abio.2001.5059
  9. Moroianu, J., Nuclear import and export pathways. J. Cell. Biochem. 33, 76-83 (1999)
  10. Nagano, S., Otsuka, T., Niiro, H., Yamaoka, K, Arinobu, Y., Ogami, E, Akahoshi, M., Inoue, Y., Miyake, K, Nakashima, H., Niho, Y, and Harada, M., Molecular mechanisms of lipopolysaccharide-induced cyclooxygenase-2 expression in human neutrophils: involvement of the mitogen-activated protein kinase pathway and regulation by anti-inflammatory cytokines. Int. Immunol. 14, 733-740 (2002) https://doi.org/10.1093/intimm/dxf038
  11. Needelman, P. and Isakson, P.C., The discovery and function of COX-2. J. Rheumatoz. 24, 6-8 (1997)
  12. Rao, A., Luo, C., and Hogan, P.G., Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707-747 (1997) https://doi.org/10.1146/annurev.immunol.15.1.707
  13. Sadikot, R.T., Christman, J.W., and Blackwell, T.S., Molecular targets for modulating lung inflammation and injury. Curro Drug Targets 5,581-588 (2004). https://doi.org/10.2174/1389450043345281
  14. Shin, H.-M., Kim, M.-H., Kim, B.H., Jung, S.-H., Kim, Y.S., Park, H.J., Hong, J.T., Min, K.R, and Kim, Y., Inhibitory action of novel aromatic diamine compound on lipopoly saccharide-induced nuclear translocation of NF-KB without affecting IKB degradation. FEBS Lett. 571, 50-54 (2004) https://doi.org/10.1016/j.febslet.2004.06.056
  15. Simon, L.S., Role and regulation of cyclooxygenase-2 during inflammation. Am. J. Med. 106, S37-42 (1999) https://doi.org/10.1016/S0002-9343(99)00115-1
  16. Stamp, L.K, Cleland, L.G., and James, MJ., Upregulation of synoviocyte COX-2 through interactions with T lymphocytes: role of interleukin 17 and tumor necrosis factor-alpha. J.Rheumatol. 31, 1246-1254 (2004)
  17. Vane, J.R and Botting, R.M., Overview-mechanisms of actions of anti-inflammatory drugs. In: Vane J, Botting J, Botting R, eds. Improved non-steroidal anti-inflammatory drugs: COX-2 enzyme inhibitors. Boston, Kluwer Academic, 1-127 (1996)
  18. Yeo, S.J., Yoon, J.G., and Yi, A.K, Myeloid differentiation factor 88-dependent post-transcriptional regulation of cyclo oxygenase-2 expression by CpG DNA: tumor necrosis factoralpha receptor-associated factor 6, a diverging point in the Toll-like receptor 9-signaling. J Biol. Chem. 278, 40590-40600 (2003) https://doi.org/10.1074/jbc.M306280200